The made-in Canada medical breakthrough that became the world’s most expensive drug, Glybera, is getting a second chance through the National Research Council of Canada. Glybera was the world’s first gene therapy and priced at $1 million for a one-time dose to treat Lipoprotein Lipase Deficiency, LPLD.
